PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 24107454-4 2014 ASA significantly increased MDA levels in both kidney and testis, whereas it significantly decreased the values of SOD, CAT, GPX, and GSH in kidney and CAT levels in testis. Aspirin 0-3 catalase Rattus norvegicus 120-123 27217606-8 2016 Aspirin decreased lipid peroxidation following SCI as the mean (+- standard error) catalase level was significantly higher in the high-dose aspirin group (46.10+-12.01) than in the sham-treated group (16.07+-2.42) and the vehicle-treated group (15.31+-3.20) (P<0.05; P<0.05, respectively). Aspirin 0-7 catalase Rattus norvegicus 83-91 27217606-8 2016 Aspirin decreased lipid peroxidation following SCI as the mean (+- standard error) catalase level was significantly higher in the high-dose aspirin group (46.10+-12.01) than in the sham-treated group (16.07+-2.42) and the vehicle-treated group (15.31+-3.20) (P<0.05; P<0.05, respectively). Aspirin 140-147 catalase Rattus norvegicus 83-91 28177735-7 2017 Aspirin induced a decrease in cell viability as well as an increase in superoxide dismutase (SOD) and catalase (CAT) activities. Aspirin 0-7 catalase Rattus norvegicus 112-115 28177735-8 2017 Contrariwise, the co-exposure of cells to aspirin and EOC alleviated every above syndrome by an increase in cell survival and decrease in SOD and CAT activities. Aspirin 42-49 catalase Rattus norvegicus 146-149 26345150-19 2015 In the aspirin-treated group compared to the control group, the NE had a protective effect on the stomach and caused less injury than aspirin, indicated by significant decreases in TNFalpha, iNOS, prostaglandin E2, and malondialdehyde levels, and also significant increases in glutathione, glutathione reductase, glutathione peroxidase, catalase, and superoxide dismutase. Aspirin 7-14 catalase Rattus norvegicus 337-345 24107454-4 2014 ASA significantly increased MDA levels in both kidney and testis, whereas it significantly decreased the values of SOD, CAT, GPX, and GSH in kidney and CAT levels in testis. Aspirin 0-3 catalase Rattus norvegicus 152-155 22626798-5 2012 RESULTS: A significant decrease in MT, SOD and CAT activities and GSH level and a significant increase in UI, AST, ALT, and ALP activities and LPO level were observed in aspirin treated stomach and duodenum of albino rats. Aspirin 170-177 catalase Rattus norvegicus 47-50 21415093-6 2011 The oral administration of ASA decreased catalase (CAT), reduced glutathione (GSH), and increased lipid peroxidation (LPO) levels. Aspirin 27-30 catalase Rattus norvegicus 51-54 20488839-9 2011 Pretreatment of IRB and ASP showed the reduction in TBARS, elevation in GSH, SOD and catalase levels as compared with MCAO rats. Aspirin 24-27 catalase Rattus norvegicus 85-93 16799884-7 2006 Moreover, coadministration of MEL and ASA increased antioxidant enzyme activities after the BDL, and these increases were statistically significant for CAT and GPx. Aspirin 38-41 catalase Rattus norvegicus 152-155 20020969-11 2007 Both the aspirin- and celecoxib-treated DMH groups showed a marked lowering of the lipid peroxide level along with a significant enhancement of CAT activity when compared with the DMH-treated group. Aspirin 9-16 catalase Rattus norvegicus 144-147 16815474-2 2006 The aim of the present work was to investigate the effect of long-term ASA administration in experimental diabetes on activities of some liver enzymes: glutathione peroxidase (GSHPx), catalase, glucose-6-phosphate dehydrogenase (G6PDH) and glutathione S-transferase (GST). Aspirin 71-74 catalase Rattus norvegicus 184-192 24688156-15 2010 In the ASA+beta-glucan group, MDA and NO levels and CAT and GSH-Px activities were found to be significantly lower, while SOD activity was found to be significantly higher, in comparison with the ASA-treated group (all, P < 0.001). Aspirin 7-10 catalase Rattus norvegicus 52-55 19009911-6 2008 CONCLUSIONS: CAT activity and MEL level decreased in the liver tissues of rats with BDL after administration of either melatonin alone or with ASA. Aspirin 143-146 catalase Rattus norvegicus 13-16 3691277-2 1987 Two enzymatic antioxidants, superoxide dismutase or catalase injected intravenously, reduced mucosal damage either by ethanol or aspirin. Aspirin 129-136 catalase Rattus norvegicus 52-60 17274466-5 2006 Catalase activity was statistically decreased after both doses of nimesulid and acetylsalicylic acid at the dose of 10 mg/kg body weight. Aspirin 80-100 catalase Rattus norvegicus 0-8 7587805-3 1995 Aspirin-induced gastric damage and the increase in myeloperoxidase activity were significantly inhibited by the injection of anti-CD11a, anti-CD11b, anti-intercellular adhesion molecule-1 monoclonal antibodies, and the combination of superoxide dismutase and catalase, which are scavengers of active oxygen species. Aspirin 0-7 catalase Rattus norvegicus 259-267 2401523-5 1990 The levels of lipid peroxide also showed a decrease while the activity of superoxide dismutase (SOD) and catalase registered an increase in the aspirin treated animals given isoproterenol when compared to corresponding animals given isoproterenol alone. Aspirin 144-151 catalase Rattus norvegicus 105-113 31608617-11 2020 The group co-administered with DHEA and aspirin showed significant increases in SOD, GST, CAT, GSH, Progesterone, Ca2+ ATPase, Na+ ATPase, H+ ATPase and significant reduction (p<0.05) in malondialdehyde, VEGF, TNF-alpha and estrogen as compared with the DHEA group. Aspirin 40-47 catalase Rattus norvegicus 90-93 166481-5 1975 Sodium citrate and aminotriazole and feeding decrease also the activity of hepatic catalase in rats fed ASA. Aspirin 104-107 catalase Rattus norvegicus 83-91 33398741-6 2021 Oral aspirin and krill oil combination significantly attenuated silica-induced oxidative stress through the restoration of reduced glutathione concentration and catalase activity in addition to alleviation of elevated malondialdehyde and total nitric oxide contents. Aspirin 5-12 catalase Rattus norvegicus 161-169